Randomized multicenter phase II trial of oxaliplatin plus irinotecan versus raltitrexed as first-line treatment in advanced colorectal cancer.

Scheithauer, Werner

Randomized multicenter phase II trial of oxaliplatin plus irinotecan versus raltitrexed as first-line treatment in advanced colorectal cancer. [electronic resource] - Journal of clinical oncology : official journal of the American Society of Clinical Oncology Jan 2002 - 165-72 p. digital

Publication Type: Clinical Trial; Clinical Trial, Phase II; Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't

0732-183X

10.1200/JCO.2002.20.1.165 doi


Adenocarcinoma--drug therapy
Adult
Aged
Antimetabolites, Antineoplastic--therapeutic use
Antineoplastic Combined Chemotherapy Protocols--adverse effects
Camptothecin--administration & dosage
Colorectal Neoplasms--drug therapy
Cross-Over Studies
Disease-Free Survival
Dose-Response Relationship, Drug
Drug Synergism
Female
Humans
Irinotecan
Male
Middle Aged
Organoplatinum Compounds--administration & dosage
Oxaliplatin
Palliative Care
Quinazolines--therapeutic use
Survival Rate
Thiophenes--therapeutic use